Purdue Pharma, creators of Oxycontin, developed and patented a new drug earlier this year aimed to help those addicted to opioids to stop top taking them. This new drug is a fast-acting form of buprenorphine. It’s a mild opioid intended to ease withdrawal symptoms.
Previously, the drug was prescribed in tablet or as fast-dissolving strips. This new prescription is a “wafer” that dissolves in the mouth within a few seconds.
Many have blamed Purdue Pharma for the epidemic of opioid painkiller addictions and deaths. Many are expressing outrage that the Sacklers, the family that owns Purdue, has profited from opioid addictions, and now plans to profit from the antidote.
- Opioids No Better than NSAIDs for Chronic Back or Arthritis Pain
- Puget Sound Mussels Contain Opioids, Antidepressants, and Chemotherapy Drugs
- Drug Firms Profiting From Addiction – Shipping Massive Quantities of Opioids To West Virginia
Stephen takes a sober look at the family behind Purdue Pharma, the company that unleashed OxyContin on the world and now looks poised to make even more profit off those who have become addicted.
Posted by The Late Show with Stephen Colbert on Saturday, September 15, 2018